Reduction of Low-Density Lipoprotein Cholesterol by Mesenchymal Stem Cells in a Mouse Model of Exogenous Cushing’s Syndrome
Tissue Engineering and Regenerative Medicine · 2025
DOI: 10.1007/s13770-024-00697-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering and Regenerative Medicine, 2025. Verfasst von Yu-Hee Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Advance Biomedical Research Institute, Ewha Womans University Seoul Hospital, Seoul, South Korea. Hauptthemen laut MEDLINE: Cushing Syndrome, Mesenchymal Stem Cells, Cholesterol, LDL, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation.
Abstract (Originalsprache)
BACKGROUND: Exogenous Cushing's syndrome, which results from prolonged glucocorticoid treatment, is associated with metabolic abnormalities. Previously, we reported the inhibitory effect of tonsil-derived mesenchymal stem cell conditioned medium (T-MSC CM) on glucocorticoid signal transduction. In this study, we investigated the therapeutic efficacy of T-MSCs in a mouse model of exogenous Cushing's syndrome. METHODS: Exogenous Cushing's syndrome model mice was generated by corticosterone administration in the drinking water for 5 weeks, and T-MSCs were injected intraperitoneally twice during the third week. Serum lipid profiles were measured using a chemistry analyzer. HepG2 cells were treated with dexamethasone and co-cultured with T-MSCs. Expression levels of genes involved in cholesterol metabolism were examined using real-time PCR. Low-density lipoprotein receptor (LDLR) protein levels were determined using western blotting and immunohistochemistry. Liver RNA extracted from the CORT and CORT + MSC mouse groups was used for transcriptome sequencing analysis and protein-protein interaction analysis. RESULTS: Weight reduction and improvements in dyslipidemia by T-MSC administration were observed only in female mice. T-MSCs reduce circulating LDL cholesterol levels by downregulating liver X receptor α (LXRα) and inducible degrader of LDLR (IDOL) expression, thereby stabilizing LDLRs in the liver. Transcriptome analysis of liver tissue revealed pathways that are regulated by T-MSCs administration. CONCLUSION: Administration of MSCs to female mice receiving chronic corticosterone treatment reduced the circulating LDL cholesterol level by downregulating the LXRα-IDOL axis in hepatocytes. These results suggest that T-MSCs may offer a novel therapeutic strategy for managing exogenous Cushing's syndrome by regulating cholesterol metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advance Biomedical Research Institute, Ewha Womans University Seoul Hospital, Seoul, South Korea.
- Ewha Medical Academy, Ewha Womans University Medical Center, Seoul, South Korea.
- Department of Microbiology, College of Medicine, Ewha Womans University, Seoul, South Korea.
- Department of Anatomy, College of Medicine, Ewha Womans University, Seoul, South Korea.
- Department of Pediatrics, College of Medicine, Ewha Womans University, Seoul, 07804, South Korea. ykh@ewha.ac.kr.
Förderung
- National Research Foundation
Zitieren
APA
Kim, Y. H., Jeong, S., Cho, K. A., Woo, S. Y., Han, S. H., & Ryu, K. H. (2025). Reduction of Low-Density Lipoprotein Cholesterol by Mesenchymal Stem Cells in a Mouse Model of Exogenous Cushing’s Syndrome. Tissue Engineering and Regenerative Medicine. https://doi.org/10.1007/s13770-024-00697-3
Vancouver
Kim YH, Jeong S, Cho KA, Woo SY, Han SH, Ryu KH. Reduction of Low-Density Lipoprotein Cholesterol by Mesenchymal Stem Cells in a Mouse Model of Exogenous Cushing’s Syndrome. Tissue Engineering and Regenerative Medicine. 2025. doi:10.1007/s13770-024-00697-3
BibTeX
@article{Kim2025,
author = {Kim, Yu-Hee and Jeong, Seonghee and Cho, Kyung-Ah and Woo, So-Youn and Han, Seung-Ho and Ryu, Kyung-Ha},
title = {Reduction of Low-Density Lipoprotein Cholesterol by Mesenchymal Stem Cells in a Mouse Model of Exogenous Cushing’s Syndrome},
journal = {Tissue Engineering and Regenerative Medicine},
year = {2025},
doi = {10.1007/s13770-024-00697-3}
}
EUVIMED